Caraco Pharmaceutical Articles
As US District Court dismisses patent use code counterclaim, all eyes move to the Supreme Court Prandin case, says law firm
22 November 2011
Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions
7 September 2010
Showing 1-5 of 5 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
